变革1型糖尿病:下一波创新浪潮
本文为综述,回顾近几十年来1型糖尿病治疗领域的重大科学进展,指出胰岛素虽非治愈手段,但新型胰岛素类似物、智能胰岛素、口服与周制剂胰岛素、葡萄糖传感器与闭环输注装置、持久性β细胞替代联合选择性免疫干预,以及1型糖尿病的预测与预防,均有望改善患者生活质量与治疗结局。
要点
- 胰岛素非治愈手段,需关注β细胞替代与免疫干预策略
- 智能胰岛素、口服及周制剂胰岛素、闭环装置是治疗创新方向
- 预测与预防进展为改变1型糖尿病自然病程提供可能
核心结论
- 1型糖尿病治疗的多项科学创新有望改善生活质量和治疗结局,但胰岛素并非治愈手段。
主要发现
- 创新涵盖新型胰岛素类似物、智能胰岛素、口服与周制剂胰岛素、葡萄糖传感器、闭环胰岛素输注装置。
- 持久性人β细胞替代联合选择性免疫调控以保护β细胞功能是潜在策略。
- 1型糖尿病的预测与预防取得进展,提示改变自然病程或消除该病的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The discovery of insulin in 1921 enabled pharmaceutical production of animal insulins for the treatment of people with type 1 diabetes by 1922. The last several decades have witnessed enormous scientific progress in the therapy of type 1 diabetes, yet some developments have been incremental, and insulin is not a cure. Herein, I highlight key scientific advances potentially poised to improve the quality of life and treatment outcomes in type 1 diabetes. These innovations range from newer insulin analogues to the development of smart insulins, oral and weekly insulins, glucose sensors and closed-loop insulin-delivery devices, as well as strategies for durable human beta cell replacement coupled with selective immune manipulation to preserve beta cell function. Finally, progress in the prediction and prevention of type 1 diabetes highlights the ongoing challenges and potential for altering the natural history of the disease or eliminating type 1 diabetes altogether.
引用
- Drucker DJ. Transforming type 1 diabetes: the next wave of innovation. Diabetologia. 2021. PMID: 33550440. doi:10.1007/s00125-021-05396-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。